Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
The Role of the Natural Killer (Nk) Cell Modulation in Breast Cancer Incidence and Progress Publisher Pubmed



Razeghian E1 ; Kameh MC2 ; Shafiee S3 ; Khalafi F3 ; Jafari F4, 5 ; Asghari M3 ; Kazemi K6 ; Ilkhani S7 ; Shariatzadeh S3 ; Hajmirzaian A8
Authors

Source: Molecular Biology Reports Published:2022


Abstract

The importance of the immune system on tumor surveillance has been investigated for many years, and its impact on controlling tumor progression has been verified. An important subgroup of the innate immune system is natural killer (NK) cells, whose essential function in modulating tumor behavior and suppressing metastasis and tumor growth has been demonstrated. The first idea of NK cells’ crucial biological processes was demonstrated through their potent ability to conduct direct cellular cytotoxicity, even without former sensitization. These properties of NK cells allow them to recognize transformed cells that have attenuated self-ligand and express stress-induced ligands. Furthermore, secretion of various cytokines and chemokines after their activation leads to tumor elimination via either direct cytotoxic effect on malignant cells or activation of the adaptive immune system. In addition, novel immunotherapeutic approaches tend to take advantage of NK cells’ ability, leading to antibody-based approaches, the formation of engineered CAR-NK cells, and adoptive cell transfer. However, the restricted functionality of NK cells and the inability to infiltrate tumors are its blind spots in breast cancer patients. In this review, we gathered newly acquired data on the biology and functions of NK cells in breast cancer and proposed ways to employ this knowledge for novel therapeutic approaches in cancers, particularly breast cancer. © 2022, The Author(s), under exclusive licence to Springer Nature B.V.
Other Related Docs
13. Car-Nk Cells for Haematological Cancers, Best Practice and Research: Clinical Haematology (2025)
15. Car-Nk Cells: A Promising Cellular Immunotherapy in Lymphoma, Expert Opinion on Biological Therapy (2023)
17. Nk Cells - Dr. Jekyll and Mr. Hyde in Autoimmune Rheumatic Diseases, International Immunopharmacology (2022)